Safra Kesesi Taşları ve Safra Yolu Taşları
Özet
Safra kesesi taşları (kolelitiazis) ve safra yolu taşları (koledokolitiazis), dünya genelinde en sık görülen hepatobiliyer hastalıklar arasında yer almakta olup önemli morbidite ve sağlık hizmeti yükü oluşturmaktadır. Hastalık asemptomatik seyir gösterebileceği gibi biliyer kolik, akut kolesistit, koledokolitiazis, akut kolanjit ve safra taşı pankreatiti gibi ciddi komplikasyonlara da yol açabilmektedir. Safra taşı oluşumunda genetik yatkınlık, yaş, kadın cinsiyet, obezite, metabolik sendrom, diyabet, gebelik ve hızlı kilo kaybı gibi çok sayıda risk faktörü rol oynamaktadır. Ultrasonografi tanıda ilk basamak görüntüleme yöntemi olup, koledok taşı şüphesi bulunan hastalarda manyetik rezonans kolanjiyopankreatografi (MRCP) ve endoskopik ultrasonografi (EUS) yüksek tanısal doğruluk sağlamaktadır. Günümüzde endoskopik retrograd kolanjiyopankreatografi (ERCP) esas olarak terapötik amaçla kullanılmakta ve özellikle koledokolitiazis ile akut kolanjit tedavisinde temel girişimsel yöntem olarak kabul edilmektedir. Semptomatik safra taşı hastalığında laparoskopik kolesistektomi standart tedavi yaklaşımıdır. Hastaların uygun şekilde değerlendirilmesi, komplikasyonların erken tanınması ve güncel kılavuzlara uygun tedavi stratejilerinin uygulanması morbidite ve mortalitenin azaltılmasında kritik öneme sahiptir.
Gallbladder stones (cholelithiasis) and common bile duct stones (choledocholithiasis) are among the most prevalent hepatobiliary disorders worldwide and represent a significant source of morbidity and healthcare burden. Although many patients remain asymptomatic, gallstone disease may lead to serious complications including biliary colic, acute cholecystitis, choledocholithiasis, acute cholangitis, and gallstone pancreatitis. Multiple factors contribute to stone formation, including genetic predisposition, advanced age, female sex, obesity, metabolic syndrome, diabetes mellitus, pregnancy, and rapid weight loss. Ultrasonography remains the first-line imaging modality for diagnosis, whereas magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasonography (EUS) provide high diagnostic accuracy in patients with suspected common bile duct stones. Endoscopic retrograde cholangiopancreatography (ERCP) is currently used primarily as a therapeutic procedure and remains the cornerstone of management for choledocholithiasis and acute cholangitis. Laparoscopic cholecystectomy is the standard treatment for symptomatic gallstone disease. Appropriate patient evaluation, early recognition of complications, and adherence to contemporary guideline-based management strategies are essential for reducing disease-related morbidity and mortality.
Referanslar
European Association for the Study of the Liver. EASL clinical practice guidelines on the prevention, diagnosis and treat¬ment of gallstones. J Hepatol. 2016;65(1):146-181.
Buxbaum JL, Abbas Fehmi SM, Sultan S, et al; ASGE Stan¬dards of Practice Committee. ASGE guideline on the role of endoscopy in the evaluation and management of choledocho¬lithiasis. Gastrointest Endosc. 2019;89(6):1075-1105.e15.
Williams E, Beckingham I, El Sayed G, et al. Updated guideli¬ne on the management of common bile duct stones (CBDS). Gut. 2017;66(5):765-782.
Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: di-agnostic criteria and severity grading of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):41-54.
Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and chole¬cystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):96-100.
Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31- 40.
Baron TH, Lee JG. Gallstones and common bile duct stones in adults. Waltham (MA): UpToDate; 2026.
Baron TH, Kozarek RA. Endoscopic retrograde cholangio-pancreatography (ERCP): indications, patient preparation and complications. Waltham (MA): UpToDate; 2026.
Chandrasekhara V, Khashab MA, Muthusamy VR, et al; ASGE Standards of Practice Committee. Adverse events asso¬ciated with ERCP. Gastrointest Endosc. 2017;85(1):32-47.
Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endos¬copy (ESGE) Guideline. Endoscopy. 2020;52(2):127-149.
Manes G, Paspatis G, Aabakken L, et al. Endoscopic mana¬gement of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019;51(5):472-491.
Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jame¬son JL, et al, eds. Harrison’s Principles of Internal Medicine. 22nd ed. New York: McGraw-Hill; 2025.
Chung RT, Rubin DT, Wilcox CM, eds. Sleisenger and Fordt¬ran’s Gastrointestinal and Liver Disease. 12th ed. Philadelphia: Elsevier; 2026.
Chandrasekhara V, Muthusamy VR, Maranki JL, et al, eds. Clinical Gastrointestinal Endoscopy. 4th ed. Philadelphia: El¬sevier; 2025.
Ekici R, Polat YH. Safra kesesi ve safra yolu taş hastalıkları. In: Yüksel M, Köseoğlu HT, Yeşil B, eds. Gastroenteroloji. Anka¬ra: Akademisyen Kitabevi; 2025.
